Entera Bio (ENTX) Metrics: History & Chart

Entera Bio Ltd.(ENTX)

Biotechnology · Jerusalem, JM

$2.53-0.09 (-3.44%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Entera Bio Ltd.

Entera Bio Ltd. is a biopharmaceutical firm in the clinical development phase, dedicated to creating and marketing oral medications composed of large molecules, addressing medical conditions that currently lack adequate treatments. Its primary experimental drugs are EB612, currently undergoing Phase II clinical assessment for hypoparathyroidism, and EB613, which has concluded Phase II studies for osteoporosis and is now in Phase I trials for treating non-healing bone fractures. Furthermore, the company holds a collaborative research and licensing pact with Amgen Inc. aimed at identifying and advancing potential therapeutic compounds for inflammatory conditions and other grave ailments. Established in 2009, Entera Bio Ltd. operates from its headquarters in Jerusalem, Israel.

Jerusalem, JM

21 employees

www.enterabio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Miranda J. Toledano

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-2.60%
30D Total Return	-12.67%
YTD Total Return	+35.05%
1Y Total Return	+37.89%
3Y Total Return	+273.73%
5Y Total Return	-42.79%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+35.05%
2025	-8.49%
2024	+253.33%
2023	-17.81%
2022	-74.11%
2021	+161.11%
2020

CAGR TTM	+37.68%
CAGR 3Y	+55.17%
CAGR 5Y	-10.57%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	1.69
PE Ratio Avg TTM	2.13
PE Ratio Avg 3Y	2.46
Current VS TTM Avg	-20.74%
Current VS 3Y Avg	-31.39%
Current VS 5Y Avg	-31.39%

All Metrics

ENTX Valuation Metrics

ENTX Stock Price Metrics

ENTX Dividend Metrics

ENTX Growth Rate Metrics

ENTX Discounted Cash Flow Metrics

ENTX Returns By Period

ENTX Yearly Returns

ENTX Average Annual Returns By Period (CAGR)

ENTX Revenue Metrics

ENTX PE Ratio Metrics

ENTX PS Ratio Metrics

ENTX PB Ratio Metrics

ENTX Price to Free Cash Flow Ratio Metrics

ENTX Debt to Equity Ratio Metrics

ENTX PEG Ratio Metrics

ENTX FCF Yield

ENTX Earnings Yield

ENTX EBITDA Yield

ENTX OCF Yield

ENTX EV/EBIT Ratio Metrics

ENTX EV/EBITDA Ratio Metrics

ENTX EV/Assets Ratio Metrics

ENTX EV/Sales Ratio Metrics

ENTX Current Ratio Metrics

ENTX Quick Ratio Metrics

ENTX ROIC Metrics

ENTX Return on Assets Metrics

ENTX Return on Equity Metrics

ENTX Net Profit Margin Metrics

ENTX Gross Profit Margin Metrics

ENTX Tax Rate Metrics

PS Ratio	1429.72
PS Ratio Avg TTM	598.28
PS Ratio Avg 3Y	839.53
Current VS TTM Avg	+138.97%
Current VS 3Y Avg	+70.30%
Current VS 5Y Avg	+181.46%

PB Ratio	18.19
PB Ratio Avg TTM	5.94
PB Ratio Avg 3Y	6.71
Current VS TTM Avg	+206.21%
Current VS 3Y Avg	+171.12%
Current VS 5Y Avg	+269.11%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.06
Debt/Equity Ratio Avg TTM	0.03
Debt/Equity Ratio Avg 3Y	0.04
Current VS TTM Avg	+78.95%
Current VS 3Y Avg	+36.23%
Current VS 5Y Avg	+111.64%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	59.28%
Earnings Yield Avg TTM	60.17%
Earnings Yield Avg 3Y	53.61%
Current VS TTM Avg	-1.48%
Current VS 3Y Avg	+10.58%
Current VS 5Y Avg	+10.58%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	3.53
Ev/Ebit Ratio Avg TTM	3.95
Ev/Ebit Ratio Avg 3Y	3.95
Current VS TTM Avg	-10.56%
Current VS 3Y Avg	-10.56%
Current VS 5Y Avg	-10.56%

Ev/Ebitda Ratio	3.51
Ev/Ebitda Ratio Avg TTM	3.93
Ev/Ebitda Ratio Avg 3Y	3.93
Current VS TTM Avg	-10.63%
Current VS 3Y Avg	-10.63%
Current VS 5Y Avg	-10.63%

Ev/Assets Ratio	6.23
Ev/Assets Ratio Avg TTM	5.01
Ev/Assets Ratio Avg 3Y	5.08
Current VS TTM Avg	+24.31%
Current VS 3Y Avg	+22.64%
Current VS 5Y Avg	+74.66%

Ev/Sales Ratio	1272.15
Ev/Sales Ratio Avg TTM	552.39
Ev/Sales Ratio Avg 3Y	660.29
Current VS TTM Avg	+130.30%
Current VS 3Y Avg	+92.66%
Current VS 5Y Avg	+217.65%

Current Ratio	8.98
Current Ratio Avg TTM	8.29
Current Ratio Avg 3Y	8.03
Current VS TTM Avg	+8.38%
Current VS 3Y Avg	+11.84%
Current VS 5Y Avg	+1.30%

Quick Ratio	8.98
Quick Ratio Avg TTM	8.29
Quick Ratio Avg 3Y	8.03
Current VS TTM Avg	+8.38%
Current VS 3Y Avg	+11.84%
Current VS 5Y Avg	+1.30%

ROIC	(82.87%)
ROIC Avg 3Y	(96.94%)
ROIC Avg 5Y	(82.97%)
Current VS 3Y Avg	+14.51%
Current VS 5Y Avg	+0.12%
Current VS 10Y Avg	+18.56%

ROA	(87.44%)
ROA Avg TTM	(23.00%)
ROA Avg 3Y	(23.01%)
Current VS TTM Avg	-280.24%
Current VS 3Y Avg	-280.09%
Current VS 5Y Avg	-365.85%

ROE	(234.42%)
ROE Avg TTM	(113.95%)
ROE Avg 3Y	(101.66%)
Current VS TTM Avg	-105.72%
Current VS 3Y Avg	-130.59%
Current VS 5Y Avg	-188.79%

Net Profit Margin	(27235.71%)
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	(1062.56%)
Current VS TTM Avg	N/A
Current VS 3Y Avg	-2463.23%
Current VS 5Y Avg	-1402.73%

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	-100.00%

Tax Rate	(3.84%)
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	(1.92%)
Current VS 3Y Avg	N/A
Current VS 5Y Avg	-100.00%
Current VS 10Y Avg	-200.00%